...
首页> 外文期刊>Heart failure reviews >Aging, telomeres and heart failure.
【24h】

Aging, telomeres and heart failure.

机译:衰老,端粒和心力衰竭。

获取原文
获取原文并翻译 | 示例
           

摘要

During normal aging, the heart undergoes functional, morphological and cellular changes. Although aging per se does not lead to the expression of heart failure, it is likely that age-associated changes lower the threshold for the manifestation of signs and symptoms of heart failure. In patients, the susceptibility, age of onset and pace of progression of heart failure are highly variable. The presence of conventional risk factors cannot completely explain this variability. Accumulation of DNA damage and telomere attrition results in an increase in cellular senescence and apoptosis, resulting in a decrease in the number and function of cells, contributing to the overall tissue and organ dysfunction. Biological aging, characterized by reduced telomere length, provides an explanation for the highly interindividual variable threshold to express the clinical syndrome of heart failure at some stage during life. In this review, we will elaborate on the current knowledge of aging of the heart, telomere biology and its potential role in the development of heart failure.
机译:在正常衰老过程中,心脏会发生功能,形态和细胞变化。尽管衰老本身并不会导致心力衰竭的表现,但与年龄相关的变化很可能会降低心力衰竭的体征和症状表现的阈值。在患者中,心力衰竭的易感性,发病年龄和进展速度变化很大。常规危险因素的存在不能完全解释这种可变性。 DNA损伤和端粒磨损的积累导致细胞衰老和凋亡增加,从而导致细胞数量和功能下降,从而导致整个组织和器官功能障碍。以衰老的端粒长度为特征的生物衰老,为在生活中某个阶段表达心力衰竭临床症状的高度个体差异阈值提供了解释。在这篇综述中,我们将详细介绍心脏衰老,端粒生物学及其在心力衰竭发展中的潜在作用的最新知识。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号